New Phase I trial data finds that people who responded to ELI-002 survived longer and stayed cancer-free longer than usual.
An experimental “off-the-shelf” vaccine for recurring pancreatic and colorectal cancer is showing great promise so far. Early results show that the vaccine appears to be safe and is potentially prolonging people’s lives.
Researchers at the University... [3113 chars]